| Literature DB >> 36267142 |
Abstract
Objective: To explore the construction of standard fast medical procedures for traumatic shock and its application effects.Entities:
Year: 2022 PMID: 36267142 PMCID: PMC9578901 DOI: 10.1155/2022/2055925
Source DB: PubMed Journal: Emerg Med Int ISSN: 2090-2840 Impact factor: 1.621
Comparison of treatment time data between the control group and the study group (n = 42, , min).
| Group | Rescue time | Consultation time | Examination time |
|---|---|---|---|
| Control group | 36.52 ± 8.66 | 25.67 ± 6.25 | 23.87 ± 5.92 |
|
| |||
| Study group | 30.46 ± 8.47 | 21.33 ± 5.86 | 20.74 ± 5.73 |
|
| |||
|
| 3.242 | 3.283 | 2.462 |
|
| |||
|
| 0.002 | 0.002 | 0.016 |
SI, blood pressure fluctuation range, and urine output.
Comparison of SI, blood pressure fluctuation range, and urine output between the control group and the study group after 18 hours of treatment ().
| Group |
| SI | Blood pressure fluctuation range (mmHg) | Urine output (ml/h) |
|---|---|---|---|---|
| Control group | 29 | 1.02 ± 0.12 | 27.54 ± 8.63 | 33.41 ± 5.11 |
| Study group | 37 | 0.71 ± 0.08 | 20.12 ± 8.34 | 36.52 ± 5.87 |
|
| 12.562 | 3.533 | 2.260 | |
|
| <0.001 | <0.001 | 0.027 |
Note. Patients who died within 18 hours of admission were excluded.
Comparison of LAC, APTT, and INR levels between the control group and the study group ().
| Group |
| LAC (mmol/L) | APTT (s) | INR | |||
|---|---|---|---|---|---|---|---|
| Before treatment | 18 h after treatment | Before treatment | 18 h after treatment | Before treatment | 18 h after treatment | ||
| Control group | 29 | 4.96 ± 1.16 | 3.62 ± 0.86 | 60.35 ± 9.54 | 52.26 ± 8.86 | 1.21 ± 0.13 | 1.32 ± 0.24 |
| Study group | 37 | 4.77 ± 1.12 | 2.27 ± 0.77 | 61.26 ± 9.67 | 47.68 ± 8.71 | 1.24 ± 0.17 | 1.47 ± 0.31 |
|
| 0.673 | 6.715 | 0.382 | 2.104 | 0.787 | 2.148 | |
|
| 0.503 | <0.001 | 0.704 | 0.040 | 0.434 | 0.036 | |
Note. Compared with before treatment, P < 0.05.
Comparison of the incidence of complications in the control group and the study group within 3 days of treatment (cases, %).
| Group |
| DIC | MODS | ARDS | Infection | Total incidence |
|---|---|---|---|---|---|---|
| Control group | 29 | 2 | 1 | 1 | 3 | 7 (24.14%) |
| Study group | 37 | 0 | 0 | 0 | 2 | 2 (5.41%) |
|
| 4.844 | |||||
|
| 0.028 |